Current Status of Cell-Based Therapies for Vitiligo
Vitiligo is a chronic pigmentary disease with complex etiology, the signs of which are caused by the destruction of melanocytes in the epidermis, leading to the lack of melanin pigment responsible for skin coloration. The treatment of vitiligo, which aims at repigmentation, depends both on the clini...
Main Authors: | Anna Domaszewska-Szostek, Agnieszka Polak, Monika Słupecka-Ziemilska, Marta Krzyżanowska, Monika Puzianowska-Kuźnicka |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/4/3357 |
Similar Items
-
Advanced Therapy Medicinal Products in Vitiligo; Current Status, Future Prospect, and Approved Treatments
by: Shahriar Ghashghaei, et al.
Published: (2023-03-01) -
The Efficacy of an Innovative Method of Melanocytes-Keratinocytes Suspension for the Treatment of Stable Vitiligo (A Report of 20 Cases)
by: Fariba Jaffary, et al.
Published: (2016-04-01) -
Aetiopathogenesis of Vitiligo
by: Katia Boniface
Published: (2023-12-01) -
A 4-year follow-up study of 20 cases of stable localized childhood vitiligo treated by autologous, noncultured melanocyte–keratinocyte cell transplantation
by: Ettappurath N Abdul Latheef, et al.
Published: (2023-01-01) -
Outcomes of autologous non-cultured melanocyte keratinocyte transplantation in vitiligo and nevus depigmentosus
by: Thanyanan Sritanyarat, et al.
Published: (2022-02-01)